belantamab mafodotin
gsk
nct03525678: phase 2 - two doses of gsk2857916 in myeloma who have failed anti-cd38 ab. dreamm 2 #mmsm #multiplemyeloma #ims2022 
Multiple Myeloma Education Platform for Myeloma Community